[HTML][HTML] Necrotic herpes simplex lymphadenitis imitating Richter's transformation in a patient with chronic lymphocytic leukemia–A case report

K Smith, M Thakker, M Kondo, E El Marabti, H Fried… - IDCases, 2023 - Elsevier
Richter Transformation (RT) is the phenomenon of progression from Chronic Lymphocytic
Leukemia (CLL) into an aggressive Large-Cell Lymphoma and is typically characterized by …

[HTML][HTML] Клиническое наблюдение эффективности совместного применения ингибиторов BCL-2 и PI3K в лечении пациента с прогностически …

ОА Рукавицын, ВП Поп, МВ Дрозд… - …, 2022 - cyberleninka.ru
Благодаря пониманию молекулярно-биологических основ патогенеза хронического
лимфолейкоза (хлл) и распределению больных в группы риска к настоящему времени …

NGS Analysis of Clonality and Minimal Residual Disease in a Patient with Concurrent Richter's Transformation and CLL/SLL

SS Kadkol, J Bland, A Kavanaugh, H Ni… - Case Reports in …, 2021 - Wiley Online Library
B‐cell lymphomas are neoplastic proliferations of clonal B lymphocytes. Clonality is
generally determined by PCR amplification of VDJ rearrangements in the IgH heavy chain or …

Approaches to Therapy of Richter Syndrome

A Condoluci, D Rossi - Clinical Lymphoma Myeloma and Leukemia, 2021 - Elsevier
Richter transformation (RT) is defined as the evolution of chronic lymphocytic leukemia/small
lymphocytic lymphoma (CLL/SLL) into an aggressive lymphoma. Occurring mostly in elderly …

Richter Syndrome

C Adalgisa, D Rossi - Current Oncology Reports, 2021 - search.proquest.com
Richter Syndrome Page 1 LYMPHOMAS (MR SMITH, SECTION EDITOR) Richter Syndrome
Adalgisa Condoluci1,2 & Davide Rossi1,2 Accepted: 17 December 2020 © The Author(s) 2021 …

A clinical case of the effective combined use of BCL-2 and PI3K inhibitors in the treatment of a patient with an unfavorable chronic lymphocytic leukemia with …

OA Rukavitsyn, VP Pop, MV Drozd… - …, 2022 - oncohematology.abvpress.ru
Understanding the molecular biological basis of chronic lymphocytic leukemia (CLL)
pathogenesis and stratification of patients into risk groups has now led to significant …

From marginal zone lymphoma to aggressive diffuse large B-cell lymphoma: a whole-exome and clinicopathological characteristics analysis of transformed lymphoma

X Zhao, H Bian, F Hao, S Shao, C Wu, Q Zhang… - 2023 - researchsquare.com
Background Transformed lymphoma occurs when indolent lymphoma transforms into more
aggressive lymphoma usually associated with poor prognosis. Methods In this study, we …

[PDF][PDF] Prognostication in Richter syndrome: context is everything

TA Eyre - British Journal of Haematology, 2020 - researchgate.net
Richter syndrome (RS) represents an aggressive transformation, most typically to diffuse
large B-cell lymphoma (DLBCL), from chronic lymphocytic leukaemia (CLL). 1, 2 The …

[PDF][PDF] Obinutuzumab, High-Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients with Richter's Syndrome. Cancers 2022, 14, 6035

BM Heyman, MY Choi, TJ Kipps - 2022 - pdfs.semanticscholar.org
Background: For patients with Richter's Syndrome (RS), a durable response is rarely
achieved with standard therapies. Significant efforts have focused on the development of …

Il ruolo della malattia residua misurabile nella leucemia linfatica cronica: valutazione citofluorimetrica dei pazienti afferenti all'Ematologia di Padova

D SCARAMUZZI - thesis.unipd.it
BACKGROUND Measurable residual disease (MRD) has shown to be a successful tool to
predict the outcome of patients with chronic lymphocytic leukemia (CLL), but according to …